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lets (CD41+), leukocytes (CD45+) and endothelium (CD31+), not erythro-
cytes (TER119+). TSP1 did not induce MP in CD47-ko mice. In vitro, we 
treated mouse bone marrow mononuclear cells (BMC), peripheral blood 
leukocytes (PBMC), endothelial cells (SVEC) and platelets with TSP1 
(10 Pg/ml) or CD47-specific domain peptide mimetic 4N1-1 (50 PM). All 
cells shed MP in response to 4N1-1 (+250%; p<0.001), except CD47-ko 
BMC. We purified MP shed in vitro by 4N1-1-treated or apoptotic BMC, 
PBMC, SVEC and platelets. We primed naïve BMC with purified MP 
(1:1) and quantified their adhesion in vitro. MP from 4N1-1-treated BMC, 
PBMC, SVEC and platelets enhanced cell adhesion by about 50% on vitro-
nectin and fibrin matrices, or endothelial monolayers (p<0.001). Apoptotic 
MP did not. We evaluated the homing of MP-primed fluorescence-labeled 
BMC to mesenteric microvessels by intravital microscopy during FeCl3-
induced thrombosis. Priming BMC with MP decreased their rolling speeds 
and increased their homing to sites of thrombosis (+50%; p<0.001). Hence, 
TSP1 signals shedding of MP in circulating and vascular cells, which acti-
vate naïve circulating cells and enhance their homing towards sites of 
thrombosis. 
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Background: Remote ischemic postconditioning (RIPost) is a powerful 
and attractive strategy of cardioprotection, though its mechanism remains 
unknown. We hypothesized that the circulating microparticules (MPs) are the 
link between the remote organ and the heart. 
Methods: MPs from rats and healthy donors undergoing RIPost were cha-
racterized. In rats, RIPost was induced by 10 min of limb ischemia. In humans, 
RIPost was induced by three cycles of 5 min inÀ ation and 5 min deÀ ation of 
a blood-pressure cuff. In the second part of the study, rats underwent 40 min 
myocardial ischemia followed by 2 hours of reperfusion. Infarct size was mea-
sured and compared among four four groups of six rats: myocardial infarc-
tion (MI); MI+RIPost started 20 min after coronary ligation; MI+injection of 
human MPs collected before RIPost (MI+MPs1); MI+injection of human MPs 
collected after RIPost (MI+MPs2).
Results: MPs from endothelial cells (CD54+) and procoagulant MPs 
(Annexin V+) markedly increased after RIPost, both in rats and humans. 
RIPost reduced infarct size (24. ±6.5% in MI+RIPost vs. 54.6±1.7% in MI 
alone, P<0.01). Infarct size did not decrease in MI+MPs1 nor in MI+MPs2, 
compared to MI alone (51.9±2.2% vs. 50.8±2.5% vs. 54.6±1.7%, respectively, 
NS).
Conclusion: RIPost increased endothelium-derived and procoagulant MPs. 
However, MP release does not appear to be a biological vector of RIPost.
0199
Microparticles as biomarkers of Crohn’s activity, inÀ ammation and 
vascular dysfunction
Daniela Leonetti [Orateur] (1), Anne-Laure Bretagne (2), Maria Carmen 
Martinez (1), Jean-Marie Reimund (2), Ramaroson Andriantsitohaina (1)
(1) INSERM U694, Angers, France – (2) 2 Service d’Hépato-Gastro-En-
térologie et Nutrition, Pôle Reins-Digestif-Nutritio, Caen, France
Microparticles (MPs) are membrane vesicles released during cell activation 
and apoptosis that have been implicated in a number of inÀ ammatory diseases 
including Crohn’s disease (CD). In a previous study, we have reported that 
active CD patients displayed increased levels of circulating MPs compared 
to healthy subjects and inactive CD patients, including MPs from platelet, 
procoagulant, leukocyte, endothelial, erythrocyte, activated leukocyte and 
activated platelet origins. Furthermore, we have shown that MPs from CD 
patients (CDMPs) impaired endothelium-dependent relaxation and promoted 
vascular hyporeactivity in aorta of mice by a subtle alteration of the balance 
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Background: Vascular calci¿ cation is a prominent complication in patients 
with chronic kidney disease (CKD) and is a strong predictor of cardiovascular 
mortality in which, smooth muscle cells (SMC) play a key role. However, 
the molecular mechanisms remain unclear. Inorganic Phosphate (Pi) is the 
major uremic toxin that is strongly correlated with SMC mineralisation. The 
aim of this study is to determine if Pi is implicated in smooth muscle cell 
proliferation.
Methods and results:  We examined the effect of Pi at 1mM (normal phy-
siological concentration), 2mM (uremic concentration) and 3mM (maximal 
uremic concentration) on human Aortic Smooth Muscle Cells (hAoSMC) 
mineralisation, proliferation, cell cycle Flow Cytometry Analysis and cell 
cycle regulatory proteins expression. HAoSMCs cultured in media containing 
normal physiological levels of Pi did not mineralize. In contrast, hAoSMCs 
cultured in media containing phosphate levels comparable to those seen in 
hyperphosphatemic individuals showed dose-dependent increases in mineral 
deposition. Cell proliferation assay shows that Pi at 2mM and 3mM reduces 
smooth muscle cell proliferation by respectively 31% (p<0,01) and 39% 
(p<0,01) vs control (Pi= 1mM). Flow cytometry analysis shows that at both 
2mM and 3mM, Pi blocks the cell cycle in G1/S transition phase. Western 
blotting analysis shows that Pi at 2mM and 3mM signi¿ cantly increases P21 
expression which negatively regulate G1/S phase cyclin dependent kinase 
(Cdk).
Conclusion: This study demonstrate that Pi, a uremic toxin which is impli-
cated in vascular calci¿ cation and cardiovascular diseases, inhibits SMC pro-
liferation by blocking the G1/S transition of cell cycle correlated with an 
increase in P21 activity. These ¿ ndings may be a useful therapeutic approach 
in preventing vascular complications in CKD patients.
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Microparticles (MP) are submicron membrane vesicles shed by activated 
or apoptotic cells. Circulating MP levels and cellular origin are modu-
lated during thrombosis, inflammation and vascular disease. But the MP 
shedding mechanism and their physiopathological impact remain unclear. 
Thrombospondin-1 (TSP1) is a large pleïotropic protein associated with 
thrombosis and secreted by activated platelets, endothelial and smooth 
muscle cells. TSP1 stimulates cytoskeletal remodeling via cell surface 
CD47. We hypothesized that TSP1 triggers MP shedding. We injected WT 
and CD47-ko transgenic mice with TSP1 (1.2 mg/Kg). Using FACS, cali-
brated beads, annexin-V labeling and mouse-specific antibodies, we found 
that TSP1 raised PS+ MP in WT mice (+260%; p<0.01), MP from plate-
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Obstructive sleep apnea (OSA) is characterized by repetitive apnea-hypo-
pnea cycles during sleep, which are associated with oxygen desaturation. It is 
an independent risk factor for cardiovascular diseases and various mechanisms 
have been proposed to contribute to the pathogenesis of vascular damage. It 
has been shown that level of circulating microparticles (MPs), small mem-
brane vesicles released during cell activation and apoptosis, is altered in OSA 
patients and contribute to endothelial dysfunction. However, their effects 
on vascular reactivity in response to agonists have not yet been assessed. 
Indeed, two age-matched groups of patients undergoing polysomnography for 
OSA were compared: 15 OSA patients with a 3% oxyhemoglobin desatura-
tion index (ODI)10 events/h of sleep and 17 control subjects with ODI<10 
events/h. MPs obtained from blood either from OSA patients or control sub-
jects, or a vehicle were injected iv to mice. Injection of MPs from OSA 
patients induced ex vivo vascular hyperreactivity in response to 5-HT in aorta. 
Hyperreactivity was not affected by inhibition of nitric oxide (NO)-synthase 
(NOS) by L-NA compared to control subjects and was associated with down-
regulation of endothelial NOS and a decrease in NO production. Both, the 
non selective cyclo-oxygenase (COX) inhibitor, indomethacin and the selec-
tive COX-2 inhibitor, NS398, reduced 5-HT-induced hyperreactivity in aorta 
from OSA MP-treated mice. This effect was associated with increased COX-2 
and NF-kB expressions but not COX-1 expression. Besides, the inhibitory 
effect of indomethacin was still effective after blockade of the NOS in aorta 
from OSA MP-treated mice. These data show that circulating MPs from OSA 
patients induce ex vivo vascular hypereactivity by an upregulation of proin-
À ammatory COX-2 and NF-kB pathway and a reduced endothelial NOS acti-
vity and NO production. These results highlight vascular dysfunction induced 
by MPs that might participate to events described in OSA patients.
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Endothelial microparticles (EMP) are shed-membrane vesicles released 
upon cell activation or apoptosis. EMP plasma levels are surrogate markers of 
endothelial dysfunction and increase in patients with cardiovascular diseases, 
but no information on the mechanisms triggering their in vivo release is avai-
lable. As laminar shear stress (SS) is the major physiological regulator of 
endothelial survival, we tested the hypothesis that SS regulates EMP release. 
ConÀ uent HUVECs were subjected to high, low SS or static conditions (15, 
1.5 and 0 dyne/cm2, respectively; 24 hrs). AnnexinV+ EMPs were analyzed by 
À ow cytometry of cell culture medium and signalling pathways were identi¿ ed 
by Western Blot analysis. HUVECs exposed to high SS released 3-fold less 
EMPs as compared to static and low SS conditions (p<0,001). As static condi-
tions and low SS promote cell apoptosis, we investigated whether or not endo-
thelial apoptosis mediated EMP shedding. Exposure to Z-VAD-FMK (20nM), 
decreased EMPs shedding by 63±7% under static conditions (p<0.001) corro-
borating Tunel assays data, but surprisingly did not affect EMP release upon 
low SS. EMP release upon low SS conditions was impaired following inhi-
bition of ERK1/2 (by 52±10%, p<0.01) and ROCK pathways (by 63±8%, 
p<0.05), but unaffected by inhibitors of p38 MAPK or NFNB pathways, which 
are involved in TNFD-induced EMP release. Low SS increased ERK1/2 phos-
phorylation (p<0.05) and this effect was inhibited following ROCK inhibi-
tion (p<0.05). The inhibitory effect of high SS on EMP release was likely to 
be mediated by NO release as L-NAME (10-5M) increased high SS-induced 
EMPs levels (p<0.001) and the NO donor SNAP (10-5M) signi¿ cantly 
decreased low SS-induced EMP release (p=0.05).
In conclusion, low SS releases procogulant EMPs via the activation of 
ROCK and ERK1/2 pathways, whereas high SS limits EMP release via NO. 
Thus, these ¿ ndings identify SS as a physiological regulator of endothelial 
microparticle release.
between NO, reactive oxygen species and metabolites from COX-2. The aim 
of the present work was to investigate a possible relationship between the total 
level and different phenotype of MPs and clinical parameters of CD patients. 
Blood samples were obtained either from CD patients as well as healthy sub-
jects. Clinical activity (determined by the Harvey-Bradshaw (HB) index) 
and biological parameters (total leucocytes, polymorphonuclear leucocytes 
(PMN), lymphocytes and platelets counts, hemoglobin (g/dL), C-reactive 
protein (CRP) (mg/L) and albumin (g/L) concentrations) were determined in 
CD patients. MPs concentration and their origin were assessed by À ow cyto-
metry using speci¿ c antibodies. Interestingly, a signi¿ cant correlation was 
found between total levels of MPs, those from platelets and endothelial cells, 
CD activity indexes and C reactive protein levels. In addition, pro-coagulant 
MP level and those from erythrocyte were positively correlated with C reac-
tive protein. Finally, only endothelial MPs were negatively correlated with 
albumin concentration. In conclusion, these data showed a correlation between 
MPs and three main criteria for CD including disease activity, inÀ ammation 
and albumin concentration and then suggest that MPs could be considered as 
important biomarker of CD disease.
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Oxidative stress plays an important role in the initial occurrence of car-
diovascular diseases. Previous studies demonstrated that microparticles (MPs) 
released from activated and apoptotic lymphocytes improve endothelial func-
tion due to their ability to decrease reactive oxygen species (ROS). Here, we 
evaluated the capacity of these MPs to modulate ROS production during acti-
nomicyn D (ActD)-induced apoptosis in human umbilical vein endothelial 
cells (HUVECs).
MPs were generated from T lymphocytes undergoing activation with phy-
tohemagglutinin and then, by stimulation with phorbol-12 myristate-13 acetate 
and ActD. HUVECs were grown for 24h in absence or presence of ActD (1g/
ml), and/or 10Pg protein/ml of MPs.
Once evaluated that MPs are able to prevent ActD-evoked apoptosis, we 
investigated the time course of modi¿ cations in ROS production (i.e. 1, 2, 4, 
6, 8, 10 and 24h) by electron paramagnetic resonance. ActD enhances ROS 
production after 2h and 10h of treatment that was prevented by MPs after 
2h but not at 10h, indicating that they act during the early phase of apop-
tosis. Interestingly at 24h, superoxide dismutase (SOD) mimetic, manganese 
(III) tetrakis (1-methyl-4-pyridyl) porphyrin (MnTMPyP) decreases cell death 
and inhibition of apoptosis induced by MPs, suggesting that MPs may behave 
as an SOD mimetic. Although these MPs carry functionally active extracel-
lular SOD and catalase, as demonstrated by western blot analysis, treatment 
of HUVECs with these MPs does not modify expression of these enzymes. 
Under the same experimental conditions, MPs increase the expressions of 
other antioxidant enzymes such as Cu/Zn SOD and Mn SOD in HUVECs 
that may explain the protective effects induced by MPs. Thus, the present 
study illustrates new mechanisms by which MPs from activated/apoptotic 
lymphocytes may confer endothelial protection under pathological conditions 
in which oxidative stress is enhanced by a subtle modulation of antioxidant 
defense mechanism.
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